Browse studies, page 1065
Page 1065 of 1,286, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Serum CRP and Fibrinogen Levels as Inflammatory Biomarkers Before and After Oral Daily Tadalafil 5 mg Treatment in Patients with Erectile Dysfunction: Case-Control Study International Journal of Medical Arts, 2024
- Comparing monotherapy with tadalafil or tamsulosin in men with benign prostatic hyperplasia: A case-control study Journal of Advanced Pharmaceutical Technology & Research, 2024
- Comparison of Hemodynamic Responses to Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension in Japan and The Netherlands: A Multicenter Study Chest, 2026
- Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab JAMA Otolaryngology - Head and Neck Surgery, 2025
- Identification of predictors of response to initial oral combination therapy in WHO-functional class II or III PAH patients: a post-hoc analysis of the AMBITION study European Heart Journal, 2020
- (188) Profiling Erectile Dysfunction in Men Under 40: A Retrospective Study of Psychogenic and Organic Etiologies and Emerging Treatment Trends Journal of Sexual Medicine, 2025
- Tadalafil Therapy for Sarcoidosis-Associated Pulmonary Hypertension Pulmonary Circulation, 2016
- Tadalafil treatment for fetus with early onset growth restriction (TADAFER) A multicenter phase II trial: 374 American Journal of Obstetrics and Gynecology, 2019
- Peyronie’s disease in Spain: a prospective study Sexual Medicine, 2026
- D15-08 Persistent Pulmonary Vascular Disease Over the Preschool Age in Children With Bronchopulmonary Dysplasia: A Catheterization-based Study American Journal of Respiratory and Critical Care Medicine, 2026
- (123) Effectiveness of Posterior Tibial Nerve Stimulation (PTNS) Therapy for Premature Ejaculation: A Propensity Score Matching Analysis Journal of Sexual Medicine, 2026
- No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study Brain Communications, 2022
- Tadalafil vs sildenafil patient preference in Spanish men with erectile dysfunction: results from an International Multicentric Study Actas Urológicas Españolas, 2006
- Association of Medication Use and 8-Year Mortality Risk in Patients With Parkinson Disease: Drug-Wide Trial Emulation Neurology, 2025
- Efficacy and tolerability of triple sequential combination therapies with selexipag in patients with pulmonary arterial hypertension: insights from a single-centre study European Heart Journal, 2024
- Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels: the Alpe2U study European Journal of Cancer, 2025
- The Association Between Phosphodiesterase-5 Inhibitors and Colorectal Cancer in a National Cohort of Patients Clinical and Translational Gastroenterology, 2020
- Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy Sarcoidosis Vasculities and Diffuse Lung Diseases, 2020
- Multicenter review of a tadalafil suspension formulation for infants and children with pulmonary hypertension: A North American experience Frontiers in Pediatrics, 2023
- (429) adherence to PDE-5 inhibitors in patients with erectile dysfunction (ED) following spinal cord injury (SCI). real life data after 10 years of treatment Journal of Sexual Medicine, 2024
- Phosphodiesterase-5 Inhibitors and Dementia Risk: A Real-World Study Neuroepidemiology, 2024
- Phase-1 clinical study of tadalafil administered for selective fetal growth restriction in twin pregnancy Journal of Maternal-Fetal & Neonatal Medicine, 2019
- Re: Role of Tamsulosin, Tadalafil and Silodosin as the Medical Expulsive Therapy in Lower Ureteric Stone: A Randomized Trial (A Pilot Study) 2015
- Dexketoprofen vs. Tamsulosin vs. Silodosin vs. Tadalafil as Medical Expulsive Therapy for Distal Ureteral Stones in Men Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2021
- Macitentan and Tadalafil Combination Therapy in Incident and Prevalent Pulmonary Arterial Hypertension: Real-World Evidence from the OPUS/OrPHeUS Studies Advances in Therapy, 2024
- (244) Population Pharmacokinetic and Economic Analysis of On-Demand Sildenafil vs. Daily Tadalafil for Erectile Dysfunction in High-Income Countries Journal of Sexual Medicine, 2026
- Benefits of Tadalafil and Sildenafil on Mortality, Cardiovascular Disease, and Dementia American Journal of Medicine, 2024
- Head-to-head Comparison of the Safety and Efficacy Profiles of Three Phosphodiesterase Type 5 Inhibitors through Patient-reported Outcomes of 130 000 Patients from a Direct-to-consumer Platform Database European Urology Focus, 2025
- Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort Infection, 2024
- The Impact of Cardiopulmonary Resuscitation Guidelines Updates Against Out-of-Hospital Shockable Cardiac Arrest: A Population-Based Cohort Study Social Science Research Network, 2021
- Using Real World Data (RWD) to Identify Care Needs in an Adolescent and Young Adult (AYA) Lymphoma Population: A Match Cohort Study Blood, 2021
- Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double-blind placebo-controlled study Pulmonary Circulation, 2021
- Is there a relationship between mean platelet volume and response to treatment with daily tadalafil in patients with erectile dysfunction? Andrologia, 2022
- Safety and Effectiveness of Once-Daily Tadalafil (5 mg) Therapy in Korean Men with Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms in a Real-World Clinical Setting: Results from a Post-Marketing Surveillance Study The World Journal of Men's Health, 2017
- Efficacy of Tadalafil in Penile Rehabilitation Started Before Nerve-Sparing Robot-Assisted Radical Prostatectomy: A Double-Blind Pilot Study Sexual Medicine, 2022
- High-throughput screening in combination with a cohort study for iodothyronine deiodinases Endocrinology, 2022
- Drugs with potential cardiac adverse effects: Retrospective study in a large cohort of parkinsonian patients Revue neurologique (Paris), 2016
- Tadalafil Use in Cardiovascular Disease Cardiology in Review, 2025
- Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany BMC Infectious Diseases, 2023
- Hyperprolactinemia-associated erectile dysfunction: retrospective cohort evaluating the effect of prolactin normalization on IIEF-5 Neuro - endocrinology letters, 2025
- Spontaneous erectile function recovery among young men with erectile dysfunction taking tadalafil 5 mg once a day Journal of Sexual Medicine, 2024
- Triple therapy for incident pulmonary arterial hypertension in Finland between 2008 and 2020. A descriptive real-world FINPAH cohort study European Heart Journal, 2023
- FRI0231 treatment of digital ulcers in patients with systemic sclerosis: prospective cohort study Annals of the Rheumatic Diseases, 2020
- Syphilis and the risk of stroke: a nationwide, population-based matched cohort study Clinical Microbiology and Infection, 2026
- Daily tadalafil administration improves cardiac autonomic regulation in men with non-organic erectile dysfunction: a prospective heart rate variability study Sexual Medicine, 2026
- Incidence and predictors of pulmonary exacerbations in primary ciliary dyskinesia: an international prospective cohort study medRxiv, 2025
- Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across sixteen countries medRxiv, 2021
- Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUS. Advances in Therapy, 2025
- Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease and mortality: An observational cohort study of elderly Medicare enrollees PLoS ONE, 2024
- Predictors of poor treatment tolerability in older patients receiving fluoropyrimidine-based chemotherapy: A prospective cohort study Journal of Geriatric Oncology, 2026
- Comment on: “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study” Drugs, 2023
- Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017–2024): a retrospective, multicentre cohort study The Lancet Regional Health - Europe, 2026
- Retrospective Observational Real-World Outcome Study to Evaluate Safety Among Patients With Erectile Dysfunction (ED) With Co-Possession of Tadalafil and Anti-Hypertensive Medications (anti-HTN) Journal of Sexual Medicine, 2021
- A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma Neuro-Oncology Advances, 2023
- Effect of long-term administration of tadalafil on arteriosclerosis: A prospective cohort study Urological Science, 2019
- Erectile dysfunction severity and penile Doppler findings in pelvic fracture urethral injury: A descriptive cohort study Indian Journal of Urology, 2026
- Real-world outcomes of tadalafil plus mirabegron combination therapy in men with lower urinary tract symptoms and overactive bladder symptoms: a retrospective cohort study The Aging Male, 2026
- Initial combination therapy with macitentan and tadalafil in pulmonary arterial hypertension: a retrospective cohort study 2021
- Analysis of the Impact of Cognitive Behavioural Therapy Combined With Tadalafil on Urination and Sexual Function Recovery in Patients With Functional Erectile Dysfunction Archivos españoles de urología, 2026
- Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort study International journal of impotence research, 2024
- Effectiveness of tadalafil and tamsulosin combination in benign prostatic hyperplasia: A prospective cohort study at a tertiary care center Asian Journal of Medical Sciences, 2023
- Comparison of Synergistic Action of Alpha Blockers and Tadalafil in the Management of Lower Ureteric Stones as Medical Expulsive Therapy: A Prospective Cohort Study Journal of Clinical and Diagnostic Research, 2023
- (426) clinical follow-UP of patients with multiple sclerosis 10 years after PDE5IS treatment for erectile dysfunction: a real-life cohort study Journal of Sexual Medicine, 2024
- Tadalafil use is associated with a lower incidence of Type 2 diabetes in men with benign prostatic hyperplasia: A population-based cohort study Journal of Internal Medicine, 2024
- Nonlinear association between vitamin D levels and response to tadalafil 5 mg daily treatment in erectile dysfunction patients: a prospective cohort study International journal of impotence research, 2026
- Risk of glaucoma among patients using tadalafil for lower urinary tract symptoms: a multinational cohort study British Journal of Ophthalmology, 2026
- Effect of Tadalafil on Prevention of Urethral Stricture after Direct Vision Internal Urethrotomy: A Prospective Cohort Study Journal of Clinical and Diagnostic Research, 2025
- Efficacy of low-intensity shockwave therapy with different tadalafil regimens in patients with PDE5 inhibitor-resistant erectile dysfunction: a retrospective cohort study International Urology and Nephrology, 2023
- Efficacy and safety of low-intensity pulsed ultrasound (LIPUS) combined with tadalafil in the treatment of severe erectile dysfunction: a retrospective cohort study Translational Andrology and Urology, 2024
- Inhaled methoxyflurane (Penthrox®) versus placebo for injury-associated analgesia in children—the MAGPIE trial (MEOF-002): study protocol for a randomised controlled trial Trials, 2019
- Phosphodiesterase 5 inhibitors for pulmonary hypertension Cochrane Database of Systematic Reviews, 2017
- Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways Journal of Cardiovascular Pharmacology and Therapeutics, 2021
- Early recognition and management of pulmonary arterial hypertension: a case for profiling Oman Medical Journal, 2012
- Re: Relationship between Lower Urinary Tract Symptoms and Cardiovascular Risk Scores Including Framingham Risk Score and ACC/AHA Risk Score Journal of Urology, 2020
- P1721 Reversible heart right failure. Pulmonary hypertension induced by Tyrosine Kinase Inhibitors 2020
- Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon Cochrane Database of Systematic Reviews, 2023
- Long-term outcomes with initial triple oral therapy in pulmonary arterial hypertension (PAH): Insights from TRITON 2020
- Phosphodiesterase type 5 inhibitors in the management of non-neurogenic male lower urinary tract symptoms: critical analysis of current evidence European Urology, 2011
- The Effect of Fluid Overload on Attributable Morbidity after Cardiac Surgery: A Retrospective Study Critical Care Research and Practice, 2020
- Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial The Lancet Respiratory Medicine, 2021
- (012) Incidence of Peyronie’s Disease After Radical Prostatectomy Among Patients Undergoing Penile Rehabilitation Regimen Journal of Sexual Medicine, 2024
- Long-term outcomes in newly diagnosed pulmonary arterial hypertension (PAH) patients receiving initial triple oral combination therapy: insights from the randomised controlled TRITON study 2020
- Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies Health and Quality of Life Outcomes, 2010
- A Rare Case of Multi-System Involvement and Hereditary Pulmonary Hypertension Caused by De Novo Heterozygous CAV1 Mutation in a Pediatric Patient Children, 2026
- Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1) Respiratory Medicine, 2017
- Real-World Impact of UGT1A1 Genotype-Guided Irinotecan Dosing on Severe Toxicity and Hospitalization: A Multicenter Study The Journal of the National Comprehensive Cancer Network, 2026
- Use of 5-phosphodiesterase inhibitors in patients with LUTS secondary to BPH: our experience and review of the literature Urologiâ, 2013
- Daily phosphodiesterase type 5 inhibitors plus acetylsalicylic acid improve curvature progression and pain intensity during the active phase of peyronie's disease Urologiâ, 2025
- The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction Journal of Sexual Medicine, 2009
- Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia BMC Urology, 2012
- Effects of once-daily tadalafil on erectile function in men with erectile dysfunction and signs and symptoms of benign prostatic hyperplasia European Urology, 2009
- Treatment effect of selexipag on time to disease progression when initiated early in pulmonary arterial hypertension (PAH) patients: GRIPHON and TRITON pooled analysis European Heart Journal, 2021
- Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease International Journal of Cardiology, 2017
- UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients European Journal of Cancer, 2022
- Folate Pathway Polymorphisms and Tadalafil Response in Men with Diabetes Mellitus and Erectile Dysfunction: An Exploratory Study Journal of Clinical Medicine, 2026
- Altering the gut microbiome and TME in advanced liver cancers: A phase II study of nivolumab, tadalafil, and oral vancomycin in refractory HCC or liver-dominant metastatic CRC or PDAC. Journal of Clinical Oncology, 2024
- Comparison between tadalafil 5 MG VS. serenoa repens/selenium/lycopene for the treatment of benign prostatic lower urinary tract symptoms secondary to benign prostatic hyperplasia. a phase IV, randomized, multicenter, non‐inferiority clinical study. sprite study.: MP09‐04 The Journal of Urology, 2017
- Re: Efficacy of tadalafil treatment in erectile dysfunction in patients receiving dutasteride treatment: A prospective nonrandomized comparative study Turkish journal of urology, 2019
- Tadalafil vs. tamsulosin in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a prospective, randomized study Central European Journal of Urology, 2019
- Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis PLoS ONE, 2015
